Spravato for Treatment-Resistant Depression: Efficacy and Sexual Side Effect Profile
Spravato (esketamine) is an innovative and effective treatment option for TRD and severe MDD, offering rapid symptom relief and a favorable sexual side effect profile. Despite logistical and financial limitations, it represents a critical advancement in personalized psychiatry, especially for patients unresponsive to conventional therapy.
Authors
- Habiba Zafar (ORCID: https://orcid.org/0000-0002-7886-9991)
- Muhammad Bin Mobin (ORCID: https://orcid.org/0000-0003-2017-8802)
- Ahmed Asad Raza (ORCID: https://orcid.org/0009-0004-2930-8188)
- Ghazi Uddin Ahmed
- Syed Owais Akhtar
- Abedin Samadi (ORCID: https://orcid.org/0009-0004-2676-9093)
Institutions
- Kabul University (AF)
- Rashid Latif Medical College (PK)
- Jinnah Sindh Medical University (PK)
Publication Details
- Journal
- Neuropsychiatric Disease and Treatment
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/ndt.s548944
- Citations
- 2
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 2.79